- Guidelines for Economic Evaluation of Pharmaceuticals in Korea
-
Bae EY
- KMID: 792541
- J Prev Med Public Health.
- 2008 Mar;41(2):80-83.
- doi: 10.3961/jpmph.2008.41.2.80
An economic evaluation is required in order to apply to the Health Insurance Review and Assessment Service (HIRA) for a listing in the national drug formulary. To assist companies in... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Economic Evaluation in the Listing and Pricing of Pharmaceuticals
-
Lee TJ
- KMID: 792539
- J Prev Med Public Health.
- 2008 Mar;41(2):69-73.
- doi: 10.3961/jpmph.2008.41.2.69
To curb a rapid increase in expenditures for pharmaceuticals, the Korean government introduced a positive list system and a negotiation process for drug prices at the end of 2006. Economic... -
- CITED
-
- Close
- SHARE
-
- Close
- Current State and Challenges of Pharmacoeconomic Evaluation in Korea
-
Choi SE
- KMID: 792540
- J Prev Med Public Health.
- 2008 Mar;41(2):74-79.
- doi: 10.3961/jpmph.2008.41.2.74
Since the positive listing system for prescription drug reimbursement has been introduced in Korea, the number of pharmacoeconomic evaluation studies has increased. However it is not clear if the quality... -
- CITED
-
- Close
- SHARE
-
- Close
